A detailed history of Bridgeway Capital Management, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 70,300 shares of BMEA stock, worth $115,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,300
Previous 35,300 99.15%
Holding current value
$115,995
Previous $75,000 68.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$1.37 - $2.9 $47,950 - $101,500
35,000 Added 99.15%
70,300 $126,000
Q1 2025

May 15, 2025

BUY
$2.13 - $4.48 $4,260 - $8,960
2,000 Added 6.01%
35,300 $75,000
Q4 2024

Feb 14, 2025

SELL
$3.88 - $12.41 $97,000 - $310,250
-25,000 Reduced 42.88%
33,300 $129,000
Q3 2024

Nov 14, 2024

BUY
$4.23 - $10.1 $246,609 - $588,830
58,300 New
58,300 $588,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $48.3M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.